The insulin antagonist ImpL2 causes cachexia in Drosophila, and IGFBPs have been implicated in mammalian cancers (Baxter, 2014; Figueroa-Clarevega and Bilder, 2015; Kwon et al., 2015). The gene discussed is INS; the disease is cancer.